Richard E. Pratley, MD | Ozempic and Wegovy Slash Kidney Disease Risks in People With Diabetes

In a recent study, health complications dropped by 24 percent in those taking semaglutide, the active ingredient in Ozempic and Wegovy. Dr. Prately was recently featured in an article on Everyday Health that discussed his recent research findings and how they can impact the larger population.


Recent News

6 items. To interact with these items, press Control-Option-Shift-Right Arrow.

AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training

“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...